3 Beaten Down Fundamentally Strong Microcap Stocks to Add to Your Watchlist

Microcap stocks often don't get much attention. They're usually overlooked because of their small size, higher volatility, or limited analyst coverage.

But within this space, there are some solid businesses that are temporarily out of favour-either due to weak market sentiment, sector-specific issues, or a few poor quarters.

Interestingly, India's Nifty Microcap 250 index has delivered over 75% returns in the past year, with some stocks more than tripling. This shows the kind of potential hidden in this segment-especially if you're willing to look beyond the noise.

We've picked out a few such microcap companies that may have been beaten down but have strong on fundamentals.

They've been selected based on the debt-to-equity ratio being under one, consistent growth in sales and profits over five years, an average RoE of over 10%, RoCE of over 15%, and a healthy cash conversion cycle under 100 days.

These are contenders to be on your watchlist if you're a long-term investor looking for value.

#1 NGL Fine Chem

First on this list is NGL Fine Chem.

NGL Fine Chem is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.

The company has a market share ranging from 15-50% in three APIs (Diminazene, Clorsulon, and Buparvaquone) and is a supplier to five of the top ten global animal healthcare companies.

In FY25, it derived approximately 92% of its revenue from animal APIs, while human APIs, intermediates, and formulations contributed around 4%, 2%, and 2% respectively.

In the last year, shares of the company have fallen 64% from their one-year high.

The company's stock faced selling pressure due to weak financial performance and a challenging operating environment.

NGL faced a sharp decline in net profit, with Q3 FY24 seeing a plummet to Rs 12.8 million (m) from Rs 100.3 m YoY, and in Q4 FY25 the company experienced a massive 95.6% consolidated net profit decline compared to the previous year.

This profit erosion was further compounded by lower revenue growth, as evidenced by a decline in total revenue for Q3 FY25 to Rs 890 m from Rs 916.3 m.

Adding to the woes were rising expenses, with total expenses increasing by 13.5% YoY to Rs 877 m in Q3 FY25, squeezing profit margins.

The company also faced a challenging operating environment characterized by soft demand from Europe, adverse currency issues in Africa, Latin America, and Turkey, and geopolitical tensions in the Middle East leading to elevated logistics costs and subdued demand.

In contrast, the company's revenue has grown at a CAGR of 16.5% in the last five years while its net profit has grown at a CAGR of 13.9%.

The company's five-year average RoE and RoCE were 21.6% and 26.1%, respectively.

To bolster its long-term growth, a significant greenfield expansion is underway at Tarapur, involving an estimated Rs 1.6 bn investment to boost production capacity by 50%.

Simultaneously, the company is focused on strengthening its global presence by enhancing its footprint in key regulated markets such as the US and Europe.

To ensure sustained competitiveness, NGL Fine Chem is prioritising cost efficiency and operational improvements, leveraging 95% in-house manufacturing and backward integration, while also investing in automation and process enhancements.

Finally, the company is committed to product diversification, developing a pipeline of new offerings to reduce reliance on a limited number of APIs and broaden its revenue streams.

To know more, check out NGL Fine Chem's financial factsheet and latest quarterly results.

#2 Arrow Greentech

Second on this list is Arrow Greentech.

Arrow Greentech is India's largest manufacturer of water-soluble films, specializing in a diverse range of PVA/PVOH (Polyvinyl Alcohol)-based films.

These environmentally friendly films are used across various applications such as agrochemical packaging, detergents, laundry bags, hydrographic printing, anti-counterfeit films, industrial consumables, and infection control bags.

Under its high-tech vertical, the company develops and manufactures advanced anti-counterfeit products, security threads, and high-security applications.

Through its subsidiary, Avery Pharmaceuticals Pvt Ltd, the company manufactures certified mouth dissolving strips (MDS) for pharmaceutical and nutraceutical applications.

In FY25, the company's revenue was bifurcated with 90% coming from high tech products and the remaining 10% from green products.

In the last year, shares of the company have fallen 55% from their one-year high.

The company's stock faced selling pressure due to revenue and profitability slump and decrease in promoter holding.

Arrow Greentech's Q4 FY25 performance showed continued weakness, with revenue falling 17.6% YoY to Rs 393 m and net profit dropping 35% during the same period.

This came after a soft Q3 FY25, where revenue fell 14% QoQ and net profit was down 31%, despite showing YoY growth.

Looking at the broader trend, the company's net profit has steadily declined over the last four quarters-from Rs 201.5 m to Rs 114.4 m, an average drop of around 16.5% each quarter.

Adding to the concerns, promoter holding has also reduced from 68.6% in June 2024 to 64.8% in March 2025.

The revenue grew at a CAGR of 24.9% in the last five years while its net profit grew at a CAGR of 190.5%.

The company's five-year average RoE and RoCE were 13.6% and 18.1%, respectively.

Arrow Greentech is looking to scale up its business through a multi-pronged growth strategy.

It is setting up a new manufacturing facility in Gujarat to increase production capacity, especially for its water-soluble and high-tech products.

The company continues to place strong emphasis on R&D and intellectual property, securing global patents and driving innovation across its product range.

In addition, Arrow is venturing into new areas such as anti-counterfeit technology and pharmaceutical delivery systems.

To know more, check out Arrow Greentech's financial factsheet and latest quarterly results.

#3 Prakash Pipes

Next on this list is Prakash Pipes.

Prakash Pipes is in the business of manufacturing PVC (Polyvinyl Chloride) pipes and fittings.

It also specializes in sustainable laminates, composites and barrier films, to create quality packaging solutions.

Currently, the company has around more than 600 dealers & retailers in PVC pipes & fittings and more than 180 customers in flexible packaging.

In the last year, shares of the company have fallen 41% from their one-year high.

The company's stock faced selling pressure due to operating margin erosion and a sharp profitability drop.

Prakash Pipes reported a sharp decline in its Q4 FY25 financials, with Profit After Tax (PAT) dropping 59.4% YoY to Rs 102.9 m from Rs 253.6 m in Q4 FY24. The decline was also significant on a sequential basis, with PAT falling 55.5% from Rs 231 m in Q3 FY25.

The operating performance was similarly weak. The operating profit fell 47.3% YoY to Rs 145.6 m and declined 51.1% QoQ.

This was accompanied by a steep contraction in operating margins, which shrank to 8% in Q4 FY25, down 52.6% from a year-ago, indicating pressure on profitability from rising costs or weaker realisations.

However, the company's revenue has grown at a CAGR of 14.4% in the last five years while its net profit has grown at a CAGR of 25.7%.

The five-year average RoE and RoCE were 24.4% and 32.2%, respectively.

The company is entering the next phase of expansion by adding CPVC (Chlorinated Polyvinyl Chloride) and UPVC (Unplasticized Polyvinyl Chloride) injection molding machines to increase its production capabilities.

Additionally, it is introducing a new product line for HDPE (High-Density Polyethylene) drums, which is crucial for the pharmaceutical, chemical, and food processing industries.

Furthermore, the company is expanding its capacities to 36,000 MT (metric tons) over the next two years, focusing on extrusion-coated and laminated structures.

To know more, check out Prakash Pipes' financial factsheet and latest quarterly results.

Conclusion

Microcap stocks are still one of the most underexplored and inefficient parts of the Indian stock market. They're often ignored because of their small size, but for investors willing to dig a little deeper, they can offer real potential.

Yes, they come with risks like short-term volatility and lower liquidity-but if you focus on companies with strong fundamentals that are just temporarily out of favour, the long-term rewards can be well worth it.

The key is to stay patient, do your homework, and take a long-term view. In a space where not many are looking, spotting value early can give you a serious edge.

Investors should evaluate the company's fundamentals, corporate governance, and valuations of the stock as key factors when conducting due diligence before making investment decisions.

Happy Investing.

Disclaimer: This article is for educational purposes only. It is not a recommendation and should not be treated as such. Learn more about our recommendation services here...